Identifying Drug-Therapy Problems among Syrian Refugees in Zaatari Refugee Camp

Int J Environ Res Public Health. 2022 Jun 12;19(12):7199. doi: 10.3390/ijerph19127199.

Abstract

Background: Due to a lack of proper pharmaceutical care, Syrian refugees in the Zaatari refugee camp are more likely to have drug-related issues, such as prescription errors and adverse drug occurrences. Aim: The current study aims to identify drug-therapy problems among Syrian refugees in the Zaatari refugee camp. Method: This is a retrospective cross-sectional study. Patients' files were collected from the Zaatari camp database. Patients who were 18 years or older and were previously diagnosed with a chronic disease were included. A classification of drug therapy problems (DTPs) was adapted. Results: The data of 1530 adult patients (896 females) were collected. The mean age of the sample was 53.7 years and the mean Body mass Index (BMI) was 27.20. The mean of all taken medications was 4.01 (±2.33) medications, with a maximum number of 13. A total of 3572 DTPs was identified, with a mean of 2.33 (±1.26) DTPs per patient. Based on the above-mentioned classification, 70.32% of the DTPs were related to indication, 26.65% were related to effectiveness, and 3.03% were related to safety. Conclusion: This study found that refugees in the Zaatari refugee camp have numerous DTPs among their medications. Greater focus should be placed on their medical care, in order to prevent any future complications due to DTPs.

Keywords: DTPs; Syrian refugees; Zaatari refugee camp; drug-therapy problems; effectiveness; safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • Humans
  • Middle Aged
  • Refugee Camps
  • Refugees*
  • Retrospective Studies
  • Syria

Grants and funding

This work was supported by Al-Zaytoonah University of Jordan, grant number 26/12/2019–2020, and by the Researchers supporting project number (RSP2022R235), King Saud University, Riyadh, Saudi Arabia.